Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
AZTA

AZTA - Azenta, Inc. Stock Price, Fair Value and News

65.21USD+0.10 (+0.15%)Market Closed
Watchlist

Market Summary

USD65.21+0.10
Market Closed
0.15%

AZTA Alerts

  • 2 major insider sales recently.
  • Big fall in Revenue (Y/Y)
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

AZTA Stock Price

View Fullscreen

AZTA RSI Chart

AZTA Valuation

Market Cap

3.6B

Price/Earnings (Trailing)

-193.99

Price/Sales (Trailing)

5.67

EV/EBITDA

51.65

Price/Free Cashflow

112.14

AZTA Price/Sales (Trailing)

AZTA Profitability

Operating Margin

25.29%

EBT Margin

-4.75%

Return on Equity

-0.77%

Return on Assets

-0.66%

Free Cashflow Yield

0.89%

AZTA Fundamentals

AZTA Revenue

Revenue (TTM)

641.0M

Rev. Growth (Yr)

-13.48%

Rev. Growth (Qtr)

-10.47%

AZTA Earnings

Earnings (TTM)

-18.7M

Earnings Growth (Yr)

-39.96%

Earnings Growth (Qtr)

-565.9%

Breaking Down AZTA Revenue

Last 7 days

-1.5%

Last 30 days

-1.5%

Last 90 days

16.3%

Trailing 12 Months

43.2%

How does AZTA drawdown profile look like?

AZTA Financial Health

Current Ratio

5.87

Debt/Equity

0.02

Debt/Cashflow

1.43

AZTA Investor Care

Dividend Yield

0.16%

Dividend/Share (TTM)

0.1

Buy Backs (1Y)

19.30%

Diluted EPS (TTM)

-0.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023597.1M630.3M665.1M641.0M
2022551.2M554.9M555.5M594.2M
2021449.2M485.0M513.7M535.2M
2020361.4M374.9M388.5M415.0M
2019709.8M741.3M334.2M347.8M
2018497.8M488.4M631.6M668.3M
2017508.1M542.2M527.5M510.1M
2016545.9M548.5M434.0M474.0M
2015501.9M529.5M552.7M549.9M
2014461.2M467.8M482.8M488.5M
2013436.9M407.3M425.7M444.7M
2012576.7M531.0M489.0M466.8M
2011709.4M738.8M688.1M630.0M
201098.5M38.5M593.0M651.2M
200900218.7M158.6M

Tracking the Latest Insider Buys and Sells of Azenta, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Feb 12, 2024
davis robyn c
acquired
162,517
65.93
2,465
-
Feb 12, 2024
rosenblatt michael
acquired
162,517
65.93
2,465
-
Feb 12, 2024
bousa edward peter
sold
-162,517
65.93
-2,465
-
Feb 12, 2024
madaus martin d
acquired
162,517
65.93
2,465
-
Feb 12, 2024
nova tina susan
sold
-162,517
65.93
-2,465
-
Feb 12, 2024
hirsch didier
acquired
162,517
65.93
2,465
-
Feb 12, 2024
mclaughlin erica
acquired
162,517
65.93
2,465
-
Feb 12, 2024
casal frank
acquired
237,546
65.93
3,603
-
Feb 01, 2024
zhou ginger
acquired
17,655
39.41
448
svp and general manager, genom
Feb 01, 2024
vacha robin
acquired
12,768
39.41
324
svp, gm life science products

1–10 of 50

Which funds bought or sold AZTA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 26, 2024
Neo Ivy Capital Management
sold off
-100
-73,000
-
-%
Feb 26, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
358,000
1,557,000
0.01%
Feb 16, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
reduced
-5.04
310,371
1,645,370
0.01%
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
reduced
-0.3
462,000
2,033,000
-%
Feb 16, 2024
HARBOUR INVESTMENTS, INC.
reduced
-77.06
-7,684
3,257
-%
Feb 15, 2024
MERCER GLOBAL ADVISORS INC /ADV
reduced
-0.92
58,000
259,000
-%
Feb 15, 2024
JANE STREET GROUP, LLC
added
50.31
26,905,100
55,202,800
0.01%
Feb 15, 2024
TOWNSQUARE CAPITAL LLC
added
7.47
773,281
2,731,640
0.05%
Feb 15, 2024
Legal & General Group Plc
added
3.57
8,075,500
31,540,300
0.01%
Feb 15, 2024
Front Row Advisors LLC
sold off
-100
-5,320
-
-%

1–10 of 45

Are Funds Buying or Selling AZTA?

Are funds buying AZTA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AZTA
No. of Funds

Unveiling Azenta, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
kayne anderson rudnick investment management llc
8.30%
4,623,311
SC 13G/A
Feb 13, 2024
vanguard group inc
10.14%
5,650,051
SC 13G/A
Jan 24, 2024
blackrock inc.
9.8%
5,462,777
SC 13G/A
Nov 15, 2023
politan capital management lp
7.92%
4,578,003
SC 13D/A
Nov 01, 2023
politan capital management lp
7.61%
4,578,003
SC 13D/A
Sep 14, 2023
politan capital management lp
6.87%
4,133,807
SC 13D
Feb 14, 2023
kayne anderson rudnick investment management llc
6.43%
4,437,157
SC 13G/A
Feb 09, 2023
william blair investment management, llc
2.6%
1,827,418
SC 13G/A
Jan 10, 2023
vanguard group inc
10.42%
7,194,160
SC 13G/A
Jan 06, 2023
blackrock inc.
10.4%
7,215,416
SC 13G/A

Recent SEC filings of Azenta, Inc.

View All Filings
Date Filed Form Type Document
Feb 14, 2024
144
Notice of Insider Sale Intent
Feb 13, 2024
4
Insider Trading
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 13, 2024
4
Insider Trading
Feb 13, 2024
4
Insider Trading
Feb 13, 2024
4
Insider Trading
Feb 13, 2024
4
Insider Trading
Feb 13, 2024
4
Insider Trading
Feb 13, 2024
4
Insider Trading

Peers (Alternatives to Azenta, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
209.0B
40.1B
0.08% 5.41%
36.51
5.21
-8.12% -17.45%
69.1B
19.5B
1.90% -2.48%
55
3.54
4.02% -22.04%
23.8B
3.9B
13.67% -2.23%
53.47
6.16
3.42% 23.09%
21.1B
14.9B
3.05% 1.38%
7.95
1.41
2.01% 209.17%
MID-CAP
10.3B
12.3B
2.56% -12.12%
24.67
0.83
-2.44% -22.68%
9.7B
2.7B
6.89% -27.73%
-15.21
3.63
-4.68% 82.43%
9.3B
3.5B
8.76% 25.90%
32.58
2.66
4.97% 18.89%
7.1B
3.9B
-8.15% -6.44%
-32.24
1.79
-2.62% 73.16%
3.5B
342.6M
-1.40% 20.18%
-289.1
10.12
42.19% 84.12%
2.6B
6.6B
-4.32% -4.67%
13.33
0.39
2.78% -0.99%
SMALL-CAP
995.5M
3.2B
8.08% -63.68%
-1.47
0.31
7.73% -1066.14%
362.7M
163.3M
8.18% -20.52%
-14.76
2.22
7.14% -56.09%
228.4M
329.5M
3.17% -52.24%
-16.18
0.69
0.49% 64.22%
72.8M
50.3M
4.50% -30.54%
-4.8
1.45
3.23% 20.81%
4.5M
3.7M
-15.66% 215.09%
-0.37
1.21
5.77% 8.23%

Azenta, Inc. News

Latest updates
AmericanBankingNEWS26 Feb 202401:41 pm
Seeking Alpha07 Feb 202408:00 am
Yahoo Finance01 Jan 202408:00 am
Investor's Business Daily3 months ago

Azenta, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-10.5%15417216614817813813314614013712913011810893.0095.0092.00148204198179
Gross Profit-9.6%62.0068.0068.0053.0074.0058.0060.0071.0067.0066.0062.0058.0057.0053.0039.0042.0039.00-10184.0081.0072.00
Operating Expenses4.2%88.0085.0084.0066.0010273.0065.0076.0067.0087.0063.0067.0057.00-14.9774.0076.0074.00-18.6467.0067.0067.00
  S&GA Expenses4.9%79.0075.0075.0073.0093.0065.0058.0068.0061.0080.0058.0062.0052.0011.0060.0060.0059.005.0053.0052.0054.00
  R&D Expenses-4.9%8.009.009.009.008.008.007.007.006.007.005.005.005.00-25.9114.0015.0014.00-24.1714.0014.0013.00
EBITDA Margin6.8%0.09*0.08*0.09*0.08*0.07*0.09*0.03*0.03*0.02*0.04*-0.05*-0.01*---------
Interest Expenses-----0.000.002.002.000.001.000.000.001.001.001.001.001.001.008.008.005.00
Income Taxes97.7%-0.19-8.44-1.21-3.26-4.642.007.00-3.17-4.68-15.46-0.80-2.30-1.55-19.515.003.00-2.96-23.267.00-1.00-5.80
Earnings Before Taxes-182.3%-15.91-5.64-3.67-5.25-15.87-3.400.00-4.99-1.82-37.88-2.60-9.651.00-81.9119.0013.0010.00-88.728.00-3.860.00
EBT Margin-3.9%-0.05*-0.05*-0.04*-0.04*-0.04*-0.02*-0.08*-0.09*-0.10*-0.10*-0.19*-0.16*---------
Net Income-565.9%-15.723.00-1.47-4.93-11.23-20.76-9.572,12043.0022.0039.0024.0026.0029.0014.009.0013.004127.003.0014.00
Net Income Margin-36.4%-0.03*-0.02*-0.06*-0.08*3.50*3.84*3.92*4.03*0.24*0.22*0.24*0.21*---------
Free Cashflow-51.1%15.0030.009.00-21.01-39.86-4.07-435-97.27-2.799.0036.0024.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-2.1%2,8242,8863,0693,2503,2923,7163,7234,1591,8551,8201,7631,6641,6151,5591,5041,4791,5591,5161,4931,4881,497
  Current Assets-2.5%1,3831,4191,5111,5861,6202,4592,5753,043797777717724675649602573663647527509521
    Cash Equivalents3.5%7036797336676086581,4741,936215227270320264251257242335257157137136
  Inventory-0.8%12712814215114686.0081.0078.0070.0060.0015512812437.0011810810599.00105109110
  Net PPE----------------10910510198.0098.0096.00
  Goodwill2.0%80078479479076151461.004684694695514.00513453500499490441491--
Liabilities8.4%381351346355421353295694488494455398363346329318400377755758767
  Current Liabilities11.7%236211204213249231195618342345311266226211206197283272175178191
  Long Term Debt---------50.0050.0050.0050.0050.0050.0050.0050.0050.0050.00535535531
    LT Debt, Current------------0.000.001.001.001.001.001.006.008.0010.00
    LT Debt, Non Current---------50.0050.0050.0050.0050.0050.0050.0050.0050.0050.00535535531
Shareholder's Equity-3.6%2,4442,5352,7242,8952,8713,3633,4283,4651,3671,3251,3081,2661,2521,2141,1751,1611,1591,139738730730
  Retained Earnings-1.0%1,6251,6411,6381,6391,6441,6551,6761,686-434-470-484-516-532-551-572-578-580-586-991-991-987
  Additional Paid-In Capital-9.6%1,0451,1561,3231,4951,4901,9921,9901,9871,9781,9761,9661,9601,9501,9431,9371,9331,9261,9221,9151,9101,903
Shares Outstanding-3.7%56.0058.0061.0069.0069.0075.0075.0075.0075.0074.0074.0074.00---------
Float----2,382---6,114---4,369---1,642---1,545-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-33.8%26,43139,91216,748-12,150-27,0209,634-419,941-71,35715,61827,11244,80334,21243,73051,79926,124-65,80025,74332,65736,01215,9656,264
  Share Based Compensation547.8%3,202-7153,9953,9912,105-49.003,485-6617,8917,1796,0867,4816,7103,9693,7244,2144,4104,9415,4555,2504,467
Cashflow From Investing-4.0%98,397102,487214,36758,17456,356-374,47831,8671,826,626-18,425-17,515-101,4512,909-30,292-10,189-8,515-17,26613,228619,393-5,872-3,610-398,599
Cashflow From Financing32.2%-113,153-166,859-172,085-416-504,7201,751-1,043-55,790-7,680-4,458-8,123-5,168-8,157-5,443-8,110-5,368-8,102-500,961-10,242-11,380331,422
  Dividend Payments---------7,4947,4387,4327,4327,4247,3867,3807,3787,3697,2377,2297,2217,208
  Buy Backs-32.1%112,953166,3981,637-500,000----------------

AZTA Income Statement

2023-12-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue  
Total revenue$ 154,317$ 178,366
Cost of revenue  
Total cost of revenue92,805104,501
Gross profit61,51273,865
Operating expenses  
Research and development8,4937,536
Selling, general and administrative78,57692,552
Restructuring charges1,1201,461
Total operating expenses88,189101,549
Operating loss(26,677)(27,685)
Other income  
Interest income, net10,08110,665
Other, net6821,145
Loss before income taxes(15,914)(15,875)
Income tax benefit(190)(4,640)
Net loss$ (15,724)$ (11,235)
Basic net loss per share:  
Basic net loss per share (in dollars per share)$ (0.28)$ (0.15)
Diluted net loss per share:  
Diluted net loss per share (in dollars per share)$ (0.28)$ (0.15)
Weighted average shares used in computing net loss per share:  
Basic (in shares)56,70972,543
Diluted (in shares)56,70972,543
Products  
Revenue  
Total revenue$ 53,393$ 85,798
Cost of revenue  
Total cost of revenue36,83854,099
Services  
Revenue  
Total revenue100,92492,568
Cost of revenue  
Total cost of revenue$ 55,967$ 50,402

AZTA Balance Sheet

2023-12-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Sep. 30, 2023
Current assets  
Cash and cash equivalents$ 702,923$ 678,910
Short-term marketable securities281,212338,873
Accounts receivable, net of allowance for expected credit losses ($7,465 and $8,057, respectively)155,926156,535
Inventories127,184128,198
Derivative asset 13,036
Short-term restricted cash4,7924,650
Prepaid expenses and other current assets110,76498,754
Total current assets1,382,8011,418,956
Property, plant and equipment, net210,628205,744
Long-term marketable securities61,962111,338
Long-term deferred tax assets1,341571
Goodwill800,166784,339
Intangible assets, net290,229294,301
Other assets77,18770,471
Total assets2,824,3142,885,720
Current liabilities  
Accounts payable40,23735,796
Deferred revenue34,81334,614
Accrued warranty and retrofit costs10,04710,223
Accrued compensation and benefits33,36833,911
Accrued customer deposits23,43217,707
Accrued VAT payable24,03320,595
Accrued income taxes payable13,2287,378
Accrued expenses and other current liabilities56,46250,704
Total current liabilities235,620210,928
Long-term tax accruals369380
Long-term deferred tax liabilities65,86567,301
Long-term operating lease liabilities66,47960,436
Other long-term liabilities12,31712,175
Total liabilities380,650351,220
Stockholders' equity  
Preferred stock, $0.01 par value - 1,000,000 shares authorized, no shares issued or outstanding
Common stock, $0.01 par value - 125,000,000 shares authorized, 69,180,281 shares issued and 55,718,412 shares outstanding at December 31, 2023, 71,294,247 shares issued and 57,832,378 shares outstanding at September 30, 2023692713
Additional paid-in capital1,045,4271,156,160
Accumulated other comprehensive loss(26,784)(62,426)
Treasury stock, at cost - 13,461,869 shares at December 31, 2023 and September 30, 2023(200,956)(200,956)
Retained earnings1,625,2851,641,009
Total stockholders' equity2,443,6642,534,500
Total liabilities and stockholders' equity$ 2,824,314$ 2,885,720
AZTA
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
 CEO
 WEBSITEwww.azenta.com
 EMPLOYEES3500

Azenta, Inc. Frequently Asked Questions


What is the ticker symbol for Azenta, Inc.? What does AZTA stand for in stocks?

AZTA is the stock ticker symbol of Azenta, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Azenta, Inc. (AZTA)?

As of Wed Feb 28 2024, market cap of Azenta, Inc. is 3.63 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AZTA stock?

You can check AZTA's fair value in chart for subscribers.

What is the fair value of AZTA stock?

You can check AZTA's fair value in chart for subscribers. The fair value of Azenta, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Azenta, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AZTA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Azenta, Inc. a good stock to buy?

The fair value guage provides a quick view whether AZTA is over valued or under valued. Whether Azenta, Inc. is cheap or expensive depends on the assumptions which impact Azenta, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AZTA.

What is Azenta, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Feb 28 2024, AZTA's PE ratio (Price to Earnings) is -193.9 and Price to Sales (PS) ratio is 5.67. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AZTA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Azenta, Inc.'s stock?

In the past 10 years, Azenta, Inc. has provided 0.216 (multiply by 100 for percentage) rate of return.